Lysosomal Acid Lipase Deficiency (LAL-D) Source for HCPs

Patients Menu Mobile

HCP Menu Mobile

LAL-D: A Life-Threatening Genetic Disease with Progressive, Multiorgan Damage Leading To Premature Death

¹

Lysosomal Acid Lipase Deficiency (LAL-D), historically known as Wolman disease and cholesteryl ester storage disease (CESD), may lead to severe systemic consequences including fibrosis, cirrhosis, cardiovascular complications, and malabsorption.^1,2

~50%

Percentage of patients who progressed to fibrosis, cirrhosis, or liver transplant within 3 years of first clinical manifestation.³

Learn About Manifestations of LAL-D

Dried Blood Spot Analysis, or DBS, test is highly accurate and easy to prepare, transport, and interpret for testing in high-risk populations.^4,5

Resources

For help diagnosing patients...

Information to help uncover LAL-D patients who might be hiding in your practice.

To participate in research...

Global registry dedicated to helping physicians improve management of LAL-D.

REGISTER TODAY

and receive all the latest LAL-D information.

^*All fields are required

First Name

Middle Name

Last Name

Title

Country

Type of Practice

Select Your Specialty

Email Address

Phone Number

By clicking Submit, I agree to the Terms of Use